Brian M. Hahn - 18 Jun 2024 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Reporting relationship: SVP Finance, CFO
Issuer ticker: GLYC
Reported as of: 18 Jun 2024
Net transaction value: +$4,335
SEC form: 4
Accepted by SEC: 20 Jun 2024, 16:15:39 UTC
Prior SEC filing: 17 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Brian F. Leaf, Attorney-in-Fact

Key filing fact

Brian M. Hahn filed Form 4 for GLYCOMIMETICS INC (GLYC) on 20 Jun 2024.

Key facts

This page summarizes Brian M. Hahn's Form 4 filing for GLYCOMIMETICS INC (GLYC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Jun 2024, 16:15.

Change

Previous filing in this sequence was filed on 17 Jan 2024.
Current net transaction value: +$4,335.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLYC transaction

Common Stock

Purchase

Transaction value: $4,335
Shares: +17,500
Change %: +33%
Price: $0.2477
Shares after: 70,643
Date: 18 Jun 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person purchased the securities on the open market at purchase prices ranging from $0.2453 to $0.2478 per share, with a weighted average purchase price of $0.2477 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.